{"ticker": {"uuid": "0511ee57-f7cb-417c-b694-04777a2c39f1", "symbol": "SRRK", "name": "Scholar Rock Holding Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/scholar-rock-reports-employee-inducement-201500091.html", "source_name": "Business Wire", "published_at": "2026-07-17T20:15:00+00:00", "published_display": "17 Jul 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "11 New Hires Get Scholar Rock Equity Awards Covering 118,586 Shares", "summary": "Scholar Rock (NASDAQ: SRRK) announced inducement equity awards totaling 118,586 shares of its common stock to eleven new employees. These awards consist of stock options for 33,987 shares and restricted stock units for 84,599 shares, granted under the company's 2022 Inducement Eq", "url": "https://www.stocktitan.net/news/SRRK/scholar-rock-reports-new-employee-inducement-grants-under-nasdaq-ksjn3t96co3p.html", "source_name": "Stock Titan", "published_at": "2026-07-17T20:09:33", "published_display": "17 Jul 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (SRRK) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary", "summary": "Scholar Rock presented at the Goldman Sachs 47th Annual Global Healthcare Conference, highlighting its lead asset, apitegromab, a late-stage myostatin inhibitor for SMA, with regulatory filings underway and anticipated launches in 2026. The company plans to commercialize apitegro", "url": "https://quartr.com/events/scholar-rock-holding-corp-srrk-goldman-sachs-47th-annual-global-healthcare-conference-2026_F9lAViQf", "source_name": "Quartr", "published_at": "2026-07-17T00:09:33", "published_display": "17 Jul 2026 00:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "SRRK, Scholar Rock Holding Corporatio Stock Prices Historical Data Shane Mosley Jr (gaOz6g1usN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE5sTG9SME80X2VvaFZXVS0tZFF6RTNHX3BRblhrWmxlRVNqZnA2Z1hpdDhkcGU5UEVlVGN2X184bW00bzZHS3d3WEIteGVmYWVtMDNrUXB0NzdXODhjc3dFNA?oc=5", "source_name": "Mshale", "published_at": "2026-07-16T18:12:14+00:00", "published_display": "16 Jul 2026 18:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (SRRK) Q3 2025 earnings summary", "summary": "Scholar Rock's Q3 2025 earnings show a net loss of $102.2 million, up from the previous year. The delay in apitegromab's U.S. approval for SMA is attributed to manufacturing compliance issues at a third-party facility, not efficacy or safety. The company is actively working to re", "url": "https://quartr.com/events/scholar-rock-holding-corp-srrk-q3-2025_F9lA6eNh", "source_name": "Quartr", "published_at": "2026-07-16T17:41:28", "published_display": "16 Jul 2026 17:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock to Report Second Quarter 2026 Financial Results on August 6, 2026", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/scholar-rock-report-second-quarter-120000910.html", "source_name": "Business Wire", "published_at": "2026-07-16T12:00:00+00:00", "published_display": "16 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock schedules Aug. 6 webcast before markets open", "summary": "Scholar Rock (NASDAQ: SRRK) announced it will report its second-quarter 2026 financial results on Thursday, August 6, 2026, before market open. The company will host a conference call and webcast with management at 8:00 a.m. ET. Interested parties can access the live audio webcas", "url": "https://www.stocktitan.net/news/SRRK/scholar-rock-to-report-second-quarter-2026-financial-results-on-f7gogp3r3kzu.html", "source_name": "Stock Titan", "published_at": "2026-07-16T11:40:22", "published_display": "16 Jul 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH", "summary": "Several biotech stocks, including American Well Corporation (AMWL), Cue Biopharma Inc. (CUE), ImmuCell Corporation (ICCC), Scholar Rock Holding Corp. (SRRK), and Faeth Therapeutics Inc. (FTH), reached 52-week highs on July 10, 2026. These gains were propelled by various catalysts", "url": "https://www.rttnews.com/3666350/biotech-stocks-at-52-week-highs-amwl-cue-iccc-srrk-fth.aspx", "source_name": "RTTNews", "published_at": "2026-07-13T11:41:23", "published_display": "13 Jul 2026 11:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding Corporation $SRRK Holdings Raised by Candriam S.C.A.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQNElXdnBTeFJDbGJSMDhwQVktaFRIZWUycXl2SzBuXzdJVWZWNjFadVRmczhybW5tNFpDLWtrVlVydkFxSHM0blhzSGRXVHdTMVdTY2l4bzlVVDJUYm9fQ04tZzZzX1hMSHlMeko0cTV3VmVGQjBUSWJxcTBuUDlzem9HLWFLODV2and1WGY3YXM1cGpUUThEZG9LQlgwMGs0bFJtd0JnSm5IbGxYRHc0MmVndk40OGp3WjlQMTJKNkZ0WENCUUxHYTFR?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-13T08:26:34+00:00", "published_display": "13 Jul 2026 08:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding (SRRK) Rallies As Pipeline Story Meets A Fair Value Question", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-12T06:27:30+00:00", "published_display": "12 Jul 2026 06:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (SRRK) Q1 2025 earnings summary", "summary": "Scholar Rock (SRRK) reported a Q1 2025 net loss of $74.7 million, up from $56.9 million in Q1 2024, with no revenue. The company is advancing its lead drug, apitegromab, which achieved positive Phase 3 results in SMA and is set for FDA priority review with a U.S. launch anticipat", "url": "https://quartr.com/events/scholar-rock-holding-corp-srrk-q1-2025_F9lAP0aB", "source_name": "Quartr", "published_at": "2026-07-10T11:41:28", "published_display": "10 Jul 2026 11:41", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock stock hits 52-week high at 56.56 USD", "summary": "Scholar Rock Holding Corp (SRRK) stock reached a new 52-week high of $56.56, marking a 56% 1-year return and reflecting strong investor confidence despite its stock potentially being overvalued according to InvestingPro. Analysts maintain a \"Strong Buy\" rating with price targets ", "url": "https://www.investing.com/news/company-news/scholar-rock-stock-hits-52week-high-at-5656-usd-93CH-4779715", "source_name": "Investing.com", "published_at": "2026-07-07T15:10:22", "published_display": "07 Jul 2026 15:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Scholar Rock Holding Corp. For: 6 July By Investing.com", "summary": "This article announces the filing of Form 144 for Scholar Rock Holding Corp. on July 6. Form 144 is a notice of the intent to sell restricted securities, typically filed by company insiders. The article indicates that full details can be found on Investing.com.", "url": "https://ca.investing.com/news/stock-market-news/form-144-scholar-rock-holding-corp-for-6-july-93CH-4721655", "source_name": "Investing.com Canada", "published_at": "2026-07-06T21:10:23", "published_display": "06 Jul 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (SRRK) director Katie Peng sells 5,446 shares under 10b5-1 tax plan", "summary": "Scholar Rock Holding Corp director Katie Peng sold 5,446 shares of common stock on July 1, 2026, under a Rule 10b5-1 trading plan. The sales, totaling $293,405, were executed to cover tax obligations arising from the vesting of restricted stock units. Following these transactions", "url": "https://www.stocktitan.net/sec-filings/SRRK/form-4-scholar-rock-holding-corp-insider-trading-activity-781c4ba4c5d4.html", "source_name": "Stock Titan", "published_at": "2026-07-06T21:10:23", "published_display": "06 Jul 2026 21:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mohammed Qatanani to sell 11,704 SRRK shares (NASDAQ: SRRK)", "summary": "Mohammed Qatanani has filed a Form 144 indicating a proposed sale of 11,704 shares of Scholar Rock Holding Corp (NASDAQ: SRRK) common stock. This sale is planned for July 6, 2026, through a stock option exercise, with J.P. Morgan Securities LLC as the broker. The filing also note", "url": "https://www.stocktitan.net/sec-filings/SRRK/144-scholar-rock-holding-corp-sec-filing-4dbaa13883cc.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:41:09", "published_display": "06 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider at Scholar Rock (SRRK) sells 2,544 shares under 10b5-1 plan", "summary": "Michael Gilman, a Director at Scholar Rock Holding Corp (SRRK), sold 2,544 shares of common stock on July 1, 2026, under a pre-arranged 10b5-1 trading plan. The sales, executed at weighted average prices between $52.97 and $55.01 per share, were made to cover tax obligations from", "url": "https://www.stocktitan.net/sec-filings/SRRK/form-4-scholar-rock-holding-corp-insider-trading-activity-826c2a63ed4f.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:41:09", "published_display": "06 Jul 2026 20:41", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (NASDAQ: SRRK) director 10b5-1 sale of 3,053 shares", "summary": "Scholar Rock Holding Corp director Jeffrey S. Flier sold 3,053 shares of common stock on July 1, 2026, through a Rule 10b-5-1 trading plan. These sales, executed at weighted average prices between $52.96 and $55.01 per share, were primarily to cover tax obligations related to the", "url": "https://www.stocktitan.net/sec-filings/SRRK/form-4-scholar-rock-holding-corp-insider-trading-activity-a824b8cdcd24.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:41:09", "published_display": "06 Jul 2026 20:41", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (SRRK) director\u2019s 3,053-share sale tied to RSU tax obligations", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOMGdpbmZ5NDdXVkgydERJU1YyWVAzVjRkSkliNmlrTFBjeHRka1RvVzgxUVdsZkRtWUQ2YlR6SDdyeXhLZ001LUhPejZveWdYbnhLSUdYaTM0T0dWTmtDc3c2a3RYS1h0ZE9jeEtmSlM3Y1B5RVQtTmJORmZVaWk0M1k5bllSSTdMZ1FRSFlnVllPMEd6cjROeEVBV251UWZDd0p1dml2c3ZWa3BvN0I0VXRPejhDcjdzZGRz?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SRRK - Scholar Rock Holding Corp Volatility & Greeks", "summary": "This article provides a detailed financial overview of Scholar Rock Holding Corp (SRRK), including its volatility, key financial metrics, stock performance, and analyst recommendations. It highlights the company's market capitalization, income, sales, and various ratios, alongsid", "url": "https://finviz.com/stock?t=SRRK&ta=1&p=d&ty=ocv&b=2&ov=list_date&e=2028-01-21", "source_name": "Finviz", "published_at": "2026-07-04T20:41:09", "published_display": "04 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Scholar Rock Holding Corp SEC Filing", "summary": "This article details a Form 144 SEC filing by Scholar Rock Holding Corp (SRRK) concerning a proposed sale of securities. The filing indicates a neutral impact and sentiment, outlining the sale of 3,053 shares of common stock with an aggregate market value of $167,274 through J.P.", "url": "https://www.stocktitan.net/sec-filings/SRRK/144-scholar-rock-holding-corp-sec-filing-196f7e856fe4.html", "source_name": "Stock Titan", "published_at": "2026-07-01T23:17:42", "published_display": "01 Jul 2026 23:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SRRK (NASDAQ: SRRK) files Rule 144 notice to sell 5,446 shares via J.P. Morgan", "summary": "Scholar Rock Holding Corp (SRRK) has filed a Rule 144 notice indicating an intention to sell 5,446 common shares through J.P. Morgan Securities LLC. These shares are related to RSU settlements scheduled for February 15, 2026 (261 shares), March 15, 2026 (745 shares), and June 15,", "url": "https://www.stocktitan.net/sec-filings/SRRK/144-scholar-rock-holding-corp-sec-filing-e5d13c8aba81.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:39:44", "published_display": "01 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Scholar Rock Holding Corp. For: 1 July By Investing.com", "summary": "This article announces the filing of Form 144 for Scholar Rock Holding Corp. on July 1st, as reported by Investing.com. The content itself is very brief and primarily serves as a placeholder for the news of this specific financial filing.", "url": "https://ca.investing.com/news/stock-market-news/form-144-scholar-rock-holding-corp-for-1-july-93CH-4717103", "source_name": "Investing.com Canada", "published_at": "2026-07-01T20:39:44", "published_display": "01 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives Consensus Recommendation of \"Buy\" from Analysts", "summary": "Scholar Rock Holding Corporation (NASDAQ:SRRK) has received a consensus \"Buy\" recommendation from 17 analysts, with an average 1-year price target of $56.00. While some recent analyst updates included price target increases, Weiss Ratings reiterated a \"sell\" rating. The stock tra", "url": "https://www.marketbeat.com/instant-alerts/scholar-rock-holding-corporation-nasdaqsrrk-receives-consensus-recommendation-of-buy-from-analysts-2026-07-01/", "source_name": "MarketBeat", "published_at": "2026-07-01T06:39:08", "published_display": "01 Jul 2026 06:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding Corp. Actuals & Estimates (NASDAQ:SRRK)", "summary": "This article provides an in-depth financial overview of Scholar Rock Holding Corporation (NASDAQ:SRRK), including its current stock price, historical performance, analyst forecasts, and key financial metrics. It covers revenue, earnings, market capitalization, and volatility, off", "url": "https://www.tradingview.com/symbols/NASDAQ-SRRK/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T10:11:12", "published_display": "27 Jun 2026 10:11", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Scholar Rock Holding Corp. \u2013 LSX:A2JMQW", "summary": "This article provides access to the forward price-to-sales ratio for Scholar Rock Holding Corp. (A2JMQW) on the Lang & Schwarz Exchange, available through TradingView. It indicates that the market is currently closed with no active trades. The content highlights the financial ove", "url": "https://www.tradingview.com/symbols/LSX-A2JMQW/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T08:11:12", "published_display": "27 Jun 2026 08:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Scholar Rock Holding Corp. \u2013 LSX:A2JMQW", "summary": "This page provides financial data for Scholar Rock Holding Corp. (LSX:A2JMQW) on TradingView, specifically focusing on its Enterprise Value to EBITDA forward metric. The content highlights that market data is provided by ICE Data Services and FactSet, with SEC filings from Quartr", "url": "https://www.tradingview.com/symbols/LSX-A2JMQW/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T02:10:15", "published_display": "27 Jun 2026 02:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding Corp. Actuals & Estimates (SWB:2QK)", "summary": "This article provides an overview of Scholar Rock Holding Corp. (SWB:2QK) including its stock ticker, analyst forecast, historical high and low prices, and financial data. It details the company's past earnings and revenue, upcoming earnings report date, and confirms it does not ", "url": "https://www.tradingview.com/symbols/SWB-2QK/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T07:10:15", "published_display": "26 Jun 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding Corp. Actuals & Estimates (BOATS:SRRK)", "summary": "This article provides financial actuals and estimates for Scholar Rock Holding Corporation (SRRK) traded on the BOATS exchange. It details analyst price targets ranging from $48.00 to $70.00, past earnings reports, and future earnings estimates. Additionally, it covers the compan", "url": "https://www.tradingview.com/symbols/BOATS-SRRK/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T06:09:23", "published_display": "26 Jun 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "2QK Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Scholar Rock Holding Corp. (2QK) stock, including analyst price targets, ratings, and financial performance. It covers historical stock prices, upcoming earnings dates, recent financial results, and details about the company's revenue, net inc", "url": "https://www.tradingview.com/symbols/SWB-2QK/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T00:41:26", "published_display": "26 Jun 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding Corp stock hits 52-week high at 52.21 USD", "summary": "Scholar Rock Holding Corp (SRRK) has reached a new 52-week high of $52.19, with shares trading around $52.11, marking a 53.5% surge over the past year. This achievement is backed by analyst optimism, with four analysts revising earnings estimates upward, despite its InvestingPro ", "url": "https://www.investing.com/news/company-news/scholar-rock-holding-corp-stock-hits-52week-high-at-5221-usd-93CH-4758398", "source_name": "Investing.com", "published_at": "2026-06-24T15:11:00", "published_display": "24 Jun 2026 15:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding eyes key EMA decision, shares trade higher on NASDAQ", "summary": "Scholar Rock Holding is nearing a key EMA review decision for its lead SMA therapy, apitegromab, which is scheduled for June 30, 2026. This comes ahead of a US FDA PDUFA date on September 30, 2026, after a recent resubmission of its biologics license application. The company's sh", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/scholar-rock-holding-eyes-key-ema-decision-shares-trade-higher-on-nasdaq/69611814", "source_name": "AD HOC NEWS", "published_at": "2026-06-23T15:09:23", "published_display": "23 Jun 2026 15:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding (SRRK) Is Up 7.1% After Apitegromab BLA Resubmission And Dual Supply Strategy - Has The Bull Case Changed?", "summary": "Scholar Rock Holding (SRRK) recently resubmitted its biologics license application for apitegromab, which now includes two fill-finish facilities and has a PDUFA date of September 30, 2026. This dual supply strategy aims to reduce operational risk for the spinal muscular atrophy ", "url": "https://www.sahmcapital.com/news/content/scholar-rock-holding-srrk-is-up-71-after-apitegromab-bla-resubmission-and-dual-supply-strategy-has-the-bull-case-changed-2026-06-23", "source_name": "Sahm", "published_at": "2026-06-22T15:40:10", "published_display": "22 Jun 2026 15:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/scholar-rock-showcase-neuromuscular-research-120000135.html", "source_name": "Business Wire", "published_at": "2026-06-22T12:00:00+00:00", "published_display": "22 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock brings new apitegromab data to two rare muscle-disease meetings", "summary": "Scholar Rock (NASDAQ: SRRK) announced it will present new clinical data and research updates related to its neuromuscular portfolio, including the Phase 3 SAPPHIRE and Phase 2 FORGE studies, at two upcoming meetings. The data will be shared at the 2026 Annual Cure SMA Research an", "url": "https://www.stocktitan.net/news/SRRK/scholar-rock-to-showcase-neuromuscular-research-portfolio-at-2026-8iyu5j9lsh59.html", "source_name": "Stock Titan", "published_at": "2026-06-22T12:12:38", "published_display": "22 Jun 2026 12:12", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding (SRRK) Stock Could Be 14.1% Undervalued On Its SMA Narrative", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNTGNIMHl3dXo2Uko5SGREVzZOUU05M3ZudXItQVpYbDR2TmFGTUZQOUUtR2dhZzVBUnlNanBCaWJ0TWFtYWJTSXdwZ0k4anZXRGVmbVZBSWZSdGdKekRSVDFNSG8zNVMtSl9fVGNTa19lTWJ4YmF4ay0ybVFjN1lMUzZNcFVjSEg0UTI4MkNOWlljYnBvQWZJQk5uVzFSTHV3VVFhc3FzeUZ0elhjaXIwMzJ3cFpNZkZEcHNkWk9vT0NwZDFXY0daWFFLcTlqbFlNNjhlSGJDWXpLWV9VOXFQM1pLeUtCQjBV0gHuAUFVX3lxTE83c0Y0T2tpMS1aMms3eE1DNzVCZW54U3FHZDg5U3NTNktzdmkwWm43ZVlZaGNzVFh5akl2QWRydjhoWlAtRC04NVVob093aU5UekhnT2xYdTBsTXZtZ1lreDdkVlVaR2N6SWh3cmh2Z2JWcWMxdUFBbXZVbDJFRDBicFM3dzllOUEyZjR5a25KZ3Y2aUI4SmQyRGtsWkxaRWVNZ25mNy1fYmFhbVZiTXZaSFFCS3dCSG9WUWpfZzdwRUdORFZfMEVuMXktYy12cnFDVUNVcU52OGlTamJtUU1DSE9tZ05jMUF2MGd0X1E?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding Corp (SRRK) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Scholar Rock Holding Corp (SRRK), detailing its current earnings forecast score, analyst ratings, and price targets. It highlights that the company's stock has an average price target of $47.50, with a majority of analysts recommendi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-srrk/earnings", "source_name": "TradingKey", "published_at": "2026-06-19T13:39:36", "published_display": "19 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cantor Fitzgerald reiterates Overweight on Scholar Rock stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQQTRUbFFobzNvUUZQX1RkVTdyalhOSDNPNlMzQmpXUEE3Wmo3dDRPWEtKdFFkNjRhY2hsMGFWQl84MDF1c0tMWnJadEY5WE1PQklMSFJ4MEN3aUpwMjNJQU5UX2ZxTkoyVG1ld3NITkU2S3gzV29yYV9NNlN5VjRiNTI2WGNKT0c5WlhVU2FZSno3dHowQ1JhQTlOZ016bktKam1mWFFTdlFhNDZEVzlNZ2tpbEV5WXBHV1NrUU9n?oc=5", "source_name": "Investing.com", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (NASDAQ: SRRK) director receives new RSU and stock option grants", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQR0ZMTWZyemR5cmpXWUNIbURHeFNzUFhnVHFzSGJMa01yR0NjbnZJQzFFQnl5VUdmRS1ubW52MVpoVm5QTWhNSUN4YUw5S1Z5Znlsd212R1I3aDVFdFQybFNPRklQZ2pDb1NGcUoyeEZyV2FZSEZNMWc5M1hGaUNrNFFCVEdMSm1tR0d6UWpnQUM0alNvbFNaQUttckVTM0RsNDRIeGFOZXdLNjIwTWxCTk10b1kxVFE4bXFn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding stock (US8063231019): fresh Nasdaq inducement grants highlight SMA hiring push", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNT3ZBSXNhLXRIaDVtdjV1SFVTejhnY05GaUFzSXFQYmdkbHJ1el9TWmRzV09GVDlTMEpMV19SUWRwUmFwbWtyUEtFbTVwOTBOV0k0T2doLVNGaTZ2c09pQ25VRnBqOVVTOUpEb1NIQjhmcE10MTMzVGY4R0xEdnpxbTcyRmVJTkFna211Y2ExczQ4TEZ1a0hTZVY0N0NBaGRJcDZVQjZnc3FUcV9QMlY4ekJaR1pkaEZTbEVPNnVPSmo0T3pUdy13Nw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings call transcript: Scholar Rock Q1 2026 sees EPS miss, stock rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQTWY4VzV3MHJqRzhWLTVyaVRLVDBIUlhvbHkxUk4tQmlvYVAzbndqRXprTGVuOF92TWFoZ3RtSGRJQ05Ub1hrOHJPb19qMUVXZzFwcHB1M3ZMUUJHcXp2VDh0c0J5dUI2RGhBcHV5Z3cxa2hDY0MyVHZtNEU1ak9pY25UQXRza2dKbHFkWmQ0Q05oMTBXal90NkRseEJRQXl2OUxpM3VWcGJNYXBlaHhqWXVoYmVmTW1PdXFQZlE4QXd0VDJLRUE?oc=5", "source_name": "Investing.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Is Scholar Rock Holding (SRRK) Offering Value After Its Strong Multi Year Share Price Gains", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/4248ce74-fce5-38f3-bfc8-fb0d3ad1ba39/scholar-rock-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-09T02:05:47+00:00", "published_display": "09 May 2026 02:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (SRRK) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/e139581e-917f-3156-94db-0423cb0ec2be/scholar-rock-%28srrk%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-08T15:30:48+00:00", "published_display": "08 May 2026 15:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Scholar Rock (SRRK) Valuation After Strong Multi Year Shareholder Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPR3BNNmtGMTZLb3JhLXpMb2hSYkF1RURNeDhXZWVYSVF5ekkyR1NjcXhpR3lodDhMQnhqZnJUNlh2NFZGd3FjQTFpb0lmTGFmdTRiTGZuZlJJRTh5R2NseXZnRDl6ZTZlSW5MeTA4a0VfV0FFQTVSbWV1OGg1bDFWUUlwN0NsUzFnVEpJZDVPSGdqclRxQmtPWWZZOVlRdw?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Don't Ignore The Insider Selling In Scholar Rock Holding", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Scholar Rock's SMA drug heads back to FDA; decision due by late Sept.", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPdDRPbmctWXk1MXBLME51cGxndzUxVTBwRXJDdUFGQ1ZGRFk5cHlSSGlyLXhhOTJHZ25jYnh2RjZVNEt0Yk41OEF4cG56T2lvV0dnZ3F0VUtNeXpTRzE0cThtRjM5c21YSlZFcTBWNHlrTkg2MlpDenN3ZzlwTThlUVowWHYtcmJGZmwtaUt3Q0dnWEJpSmd4bXVTY3JvU2NTSnJGYzh5bHdtNzhGdEhUUlB0eW1XU0VFZXFpTTVtbw?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Scholar Rock Holding (SRRK) Valuation As Growth Expectations Face Mixed Share Price Signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNYWtUbGk5MDM2ZThJQWtEREt0N25lek5PaVpWSVhnMF9jRHB3aGEtVkZDZXAyNEd3SFFtQ0Y2MU1iclZkNXlTUEZ1bUlMeFBhcnZxOHBoS3VDel9rR0syVmtONy1PeVY4M3hvU2xZdkQ4emZIRF9lQTZRcjJvQjhFMkRTRk1JMzd5QlVCb2xyWkE5b0ZLVXpuSy1RQQ?oc=5", "source_name": "Market source", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn\u2019t Pleased", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPeTlKeFlQNTdaT1MwVjYwc0FxNkhNdmpuRGFzWlN3OTJncEgzS1dsdG02V2hpQmxrcXBSZmFVU2UxeC1tX3o3U0k4VmhIQlNmTkFET1JyWHdRRkZnNzBoQmc5NWVSOXRzVGtfY2hKcUhlQURvSm4yRmllRHB4dkpJRml5MTVoLWNWLUZxQXJqeWZxYnFmdWVHajFhOEVmYUpDeXR2Wk0xWUszaHc2bmUteS1ReTJUZnBOLVh4WUxQMWlaNmZWNXRnMm40Qy1aOE43aG1VVUw0Z3llb3VYOG4tNFU1UQ?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US FDA declines to approve Scholar Rock's muscle weakness drug; shares fall", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPd2RTZW5WNmxXcGZ5a05kM1p1bXFzNXJLMV8tb1ROVVF2S0NPUzcyY1h6OFlYd0xGaENFdklsZEk2OUpFdC0wajN2ZWVRNUhwT0l6anc0SnpaeHdIakp3bmZxWGhkT194TEZCal9zVU5qRHJXOE9YWUZwN3ctd1FEOElmX2xKdURrN0R1UXEyclA0ZWNOSWpEOU9nbDZfTW5oZXU2bXlic0Q1b1QyT3hGWmd1N2FFSGozREFwUXQySHFQR2NoT081Yk5R?oc=5", "source_name": "Reuters", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "negative", "sentiment_pct": 6, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/scholar-rock-reports-employee-inducement-201500091.html", "source_name": "Business Wire", "published_at": "2026-07-17T20:15:00+00:00", "published_display": "17 Jul 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "11 New Hires Get Scholar Rock Equity Awards Covering 118,586 Shares", "summary": "Scholar Rock (NASDAQ: SRRK) announced inducement equity awards totaling 118,586 shares of its common stock to eleven new employees. These awards consist of stock options for 33,987 shares and restricted stock units for 84,599 shares, granted under the company's 2022 Inducement Eq", "url": "https://www.stocktitan.net/news/SRRK/scholar-rock-reports-new-employee-inducement-grants-under-nasdaq-ksjn3t96co3p.html", "source_name": "Stock Titan", "published_at": "2026-07-17T20:09:33", "published_display": "17 Jul 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (SRRK) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary", "summary": "Scholar Rock presented at the Goldman Sachs 47th Annual Global Healthcare Conference, highlighting its lead asset, apitegromab, a late-stage myostatin inhibitor for SMA, with regulatory filings underway and anticipated launches in 2026. The company plans to commercialize apitegro", "url": "https://quartr.com/events/scholar-rock-holding-corp-srrk-goldman-sachs-47th-annual-global-healthcare-conference-2026_F9lAViQf", "source_name": "Quartr", "published_at": "2026-07-17T00:09:33", "published_display": "17 Jul 2026 00:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SRRK, Scholar Rock Holding Corporatio Stock Prices Historical Data Shane Mosley Jr (gaOz6g1usN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE5sTG9SME80X2VvaFZXVS0tZFF6RTNHX3BRblhrWmxlRVNqZnA2Z1hpdDhkcGU5UEVlVGN2X184bW00bzZHS3d3WEIteGVmYWVtMDNrUXB0NzdXODhjc3dFNA?oc=5", "source_name": "Mshale", "published_at": "2026-07-16T18:12:14+00:00", "published_display": "16 Jul 2026 18:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (SRRK) Q3 2025 earnings summary", "summary": "Scholar Rock's Q3 2025 earnings show a net loss of $102.2 million, up from the previous year. The delay in apitegromab's U.S. approval for SMA is attributed to manufacturing compliance issues at a third-party facility, not efficacy or safety. The company is actively working to re", "url": "https://quartr.com/events/scholar-rock-holding-corp-srrk-q3-2025_F9lA6eNh", "source_name": "Quartr", "published_at": "2026-07-16T17:41:28", "published_display": "16 Jul 2026 17:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock to Report Second Quarter 2026 Financial Results on August 6, 2026", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/scholar-rock-report-second-quarter-120000910.html", "source_name": "Business Wire", "published_at": "2026-07-16T12:00:00+00:00", "published_display": "16 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock schedules Aug. 6 webcast before markets open", "summary": "Scholar Rock (NASDAQ: SRRK) announced it will report its second-quarter 2026 financial results on Thursday, August 6, 2026, before market open. The company will host a conference call and webcast with management at 8:00 a.m. ET. Interested parties can access the live audio webcas", "url": "https://www.stocktitan.net/news/SRRK/scholar-rock-to-report-second-quarter-2026-financial-results-on-f7gogp3r3kzu.html", "source_name": "Stock Titan", "published_at": "2026-07-16T11:40:22", "published_display": "16 Jul 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH", "summary": "Several biotech stocks, including American Well Corporation (AMWL), Cue Biopharma Inc. (CUE), ImmuCell Corporation (ICCC), Scholar Rock Holding Corp. (SRRK), and Faeth Therapeutics Inc. (FTH), reached 52-week highs on July 10, 2026. These gains were propelled by various catalysts", "url": "https://www.rttnews.com/3666350/biotech-stocks-at-52-week-highs-amwl-cue-iccc-srrk-fth.aspx", "source_name": "RTTNews", "published_at": "2026-07-13T11:41:23", "published_display": "13 Jul 2026 11:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding Corporation $SRRK Holdings Raised by Candriam S.C.A.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQNElXdnBTeFJDbGJSMDhwQVktaFRIZWUycXl2SzBuXzdJVWZWNjFadVRmczhybW5tNFpDLWtrVlVydkFxSHM0blhzSGRXVHdTMVdTY2l4bzlVVDJUYm9fQ04tZzZzX1hMSHlMeko0cTV3VmVGQjBUSWJxcTBuUDlzem9HLWFLODV2and1WGY3YXM1cGpUUThEZG9LQlgwMGs0bFJtd0JnSm5IbGxYRHc0MmVndk40OGp3WjlQMTJKNkZ0WENCUUxHYTFR?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-13T08:26:34+00:00", "published_display": "13 Jul 2026 08:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding (SRRK) Rallies As Pipeline Story Meets A Fair Value Question", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-12T06:27:30+00:00", "published_display": "12 Jul 2026 06:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (SRRK) Q1 2025 earnings summary", "summary": "Scholar Rock (SRRK) reported a Q1 2025 net loss of $74.7 million, up from $56.9 million in Q1 2024, with no revenue. The company is advancing its lead drug, apitegromab, which achieved positive Phase 3 results in SMA and is set for FDA priority review with a U.S. launch anticipat", "url": "https://quartr.com/events/scholar-rock-holding-corp-srrk-q1-2025_F9lAP0aB", "source_name": "Quartr", "published_at": "2026-07-10T11:41:28", "published_display": "10 Jul 2026 11:41", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock stock hits 52-week high at 56.56 USD", "summary": "Scholar Rock Holding Corp (SRRK) stock reached a new 52-week high of $56.56, marking a 56% 1-year return and reflecting strong investor confidence despite its stock potentially being overvalued according to InvestingPro. Analysts maintain a \"Strong Buy\" rating with price targets ", "url": "https://www.investing.com/news/company-news/scholar-rock-stock-hits-52week-high-at-5656-usd-93CH-4779715", "source_name": "Investing.com", "published_at": "2026-07-07T15:10:22", "published_display": "07 Jul 2026 15:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Scholar Rock Holding Corp. For: 6 July By Investing.com", "summary": "This article announces the filing of Form 144 for Scholar Rock Holding Corp. on July 6. Form 144 is a notice of the intent to sell restricted securities, typically filed by company insiders. The article indicates that full details can be found on Investing.com.", "url": "https://ca.investing.com/news/stock-market-news/form-144-scholar-rock-holding-corp-for-6-july-93CH-4721655", "source_name": "Investing.com Canada", "published_at": "2026-07-06T21:10:23", "published_display": "06 Jul 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (SRRK) director Katie Peng sells 5,446 shares under 10b5-1 tax plan", "summary": "Scholar Rock Holding Corp director Katie Peng sold 5,446 shares of common stock on July 1, 2026, under a Rule 10b5-1 trading plan. The sales, totaling $293,405, were executed to cover tax obligations arising from the vesting of restricted stock units. Following these transactions", "url": "https://www.stocktitan.net/sec-filings/SRRK/form-4-scholar-rock-holding-corp-insider-trading-activity-781c4ba4c5d4.html", "source_name": "Stock Titan", "published_at": "2026-07-06T21:10:23", "published_display": "06 Jul 2026 21:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mohammed Qatanani to sell 11,704 SRRK shares (NASDAQ: SRRK)", "summary": "Mohammed Qatanani has filed a Form 144 indicating a proposed sale of 11,704 shares of Scholar Rock Holding Corp (NASDAQ: SRRK) common stock. This sale is planned for July 6, 2026, through a stock option exercise, with J.P. Morgan Securities LLC as the broker. The filing also note", "url": "https://www.stocktitan.net/sec-filings/SRRK/144-scholar-rock-holding-corp-sec-filing-4dbaa13883cc.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:41:09", "published_display": "06 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider at Scholar Rock (SRRK) sells 2,544 shares under 10b5-1 plan", "summary": "Michael Gilman, a Director at Scholar Rock Holding Corp (SRRK), sold 2,544 shares of common stock on July 1, 2026, under a pre-arranged 10b5-1 trading plan. The sales, executed at weighted average prices between $52.97 and $55.01 per share, were made to cover tax obligations from", "url": "https://www.stocktitan.net/sec-filings/SRRK/form-4-scholar-rock-holding-corp-insider-trading-activity-826c2a63ed4f.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:41:09", "published_display": "06 Jul 2026 20:41", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (NASDAQ: SRRK) director 10b5-1 sale of 3,053 shares", "summary": "Scholar Rock Holding Corp director Jeffrey S. Flier sold 3,053 shares of common stock on July 1, 2026, through a Rule 10b-5-1 trading plan. These sales, executed at weighted average prices between $52.96 and $55.01 per share, were primarily to cover tax obligations related to the", "url": "https://www.stocktitan.net/sec-filings/SRRK/form-4-scholar-rock-holding-corp-insider-trading-activity-a824b8cdcd24.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:41:09", "published_display": "06 Jul 2026 20:41", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (SRRK) director\u2019s 3,053-share sale tied to RSU tax obligations", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOMGdpbmZ5NDdXVkgydERJU1YyWVAzVjRkSkliNmlrTFBjeHRka1RvVzgxUVdsZkRtWUQ2YlR6SDdyeXhLZ001LUhPejZveWdYbnhLSUdYaTM0T0dWTmtDc3c2a3RYS1h0ZE9jeEtmSlM3Y1B5RVQtTmJORmZVaWk0M1k5bllSSTdMZ1FRSFlnVllPMEd6cjROeEVBV251UWZDd0p1dml2c3ZWa3BvN0I0VXRPejhDcjdzZGRz?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SRRK - Scholar Rock Holding Corp Volatility & Greeks", "summary": "This article provides a detailed financial overview of Scholar Rock Holding Corp (SRRK), including its volatility, key financial metrics, stock performance, and analyst recommendations. It highlights the company's market capitalization, income, sales, and various ratios, alongsid", "url": "https://finviz.com/stock?t=SRRK&ta=1&p=d&ty=ocv&b=2&ov=list_date&e=2028-01-21", "source_name": "Finviz", "published_at": "2026-07-04T20:41:09", "published_display": "04 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Scholar Rock Holding Corp SEC Filing", "summary": "This article details a Form 144 SEC filing by Scholar Rock Holding Corp (SRRK) concerning a proposed sale of securities. The filing indicates a neutral impact and sentiment, outlining the sale of 3,053 shares of common stock with an aggregate market value of $167,274 through J.P.", "url": "https://www.stocktitan.net/sec-filings/SRRK/144-scholar-rock-holding-corp-sec-filing-196f7e856fe4.html", "source_name": "Stock Titan", "published_at": "2026-07-01T23:17:42", "published_display": "01 Jul 2026 23:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SRRK (NASDAQ: SRRK) files Rule 144 notice to sell 5,446 shares via J.P. Morgan", "summary": "Scholar Rock Holding Corp (SRRK) has filed a Rule 144 notice indicating an intention to sell 5,446 common shares through J.P. Morgan Securities LLC. These shares are related to RSU settlements scheduled for February 15, 2026 (261 shares), March 15, 2026 (745 shares), and June 15,", "url": "https://www.stocktitan.net/sec-filings/SRRK/144-scholar-rock-holding-corp-sec-filing-e5d13c8aba81.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:39:44", "published_display": "01 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Scholar Rock Holding Corp. For: 1 July By Investing.com", "summary": "This article announces the filing of Form 144 for Scholar Rock Holding Corp. on July 1st, as reported by Investing.com. The content itself is very brief and primarily serves as a placeholder for the news of this specific financial filing.", "url": "https://ca.investing.com/news/stock-market-news/form-144-scholar-rock-holding-corp-for-1-july-93CH-4717103", "source_name": "Investing.com Canada", "published_at": "2026-07-01T20:39:44", "published_display": "01 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives Consensus Recommendation of \"Buy\" from Analysts", "summary": "Scholar Rock Holding Corporation (NASDAQ:SRRK) has received a consensus \"Buy\" recommendation from 17 analysts, with an average 1-year price target of $56.00. While some recent analyst updates included price target increases, Weiss Ratings reiterated a \"sell\" rating. The stock tra", "url": "https://www.marketbeat.com/instant-alerts/scholar-rock-holding-corporation-nasdaqsrrk-receives-consensus-recommendation-of-buy-from-analysts-2026-07-01/", "source_name": "MarketBeat", "published_at": "2026-07-01T06:39:08", "published_display": "01 Jul 2026 06:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding Corp. Actuals & Estimates (NASDAQ:SRRK)", "summary": "This article provides an in-depth financial overview of Scholar Rock Holding Corporation (NASDAQ:SRRK), including its current stock price, historical performance, analyst forecasts, and key financial metrics. It covers revenue, earnings, market capitalization, and volatility, off", "url": "https://www.tradingview.com/symbols/NASDAQ-SRRK/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T10:11:12", "published_display": "27 Jun 2026 10:11", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Scholar Rock Holding Corp. \u2013 LSX:A2JMQW", "summary": "This article provides access to the forward price-to-sales ratio for Scholar Rock Holding Corp. (A2JMQW) on the Lang & Schwarz Exchange, available through TradingView. It indicates that the market is currently closed with no active trades. The content highlights the financial ove", "url": "https://www.tradingview.com/symbols/LSX-A2JMQW/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T08:11:12", "published_display": "27 Jun 2026 08:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Scholar Rock Holding Corp. \u2013 LSX:A2JMQW", "summary": "This page provides financial data for Scholar Rock Holding Corp. (LSX:A2JMQW) on TradingView, specifically focusing on its Enterprise Value to EBITDA forward metric. The content highlights that market data is provided by ICE Data Services and FactSet, with SEC filings from Quartr", "url": "https://www.tradingview.com/symbols/LSX-A2JMQW/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T02:10:15", "published_display": "27 Jun 2026 02:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding Corp. Actuals & Estimates (SWB:2QK)", "summary": "This article provides an overview of Scholar Rock Holding Corp. (SWB:2QK) including its stock ticker, analyst forecast, historical high and low prices, and financial data. It details the company's past earnings and revenue, upcoming earnings report date, and confirms it does not ", "url": "https://www.tradingview.com/symbols/SWB-2QK/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T07:10:15", "published_display": "26 Jun 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding Corp. Actuals & Estimates (BOATS:SRRK)", "summary": "This article provides financial actuals and estimates for Scholar Rock Holding Corporation (SRRK) traded on the BOATS exchange. It details analyst price targets ranging from $48.00 to $70.00, past earnings reports, and future earnings estimates. Additionally, it covers the compan", "url": "https://www.tradingview.com/symbols/BOATS-SRRK/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T06:09:23", "published_display": "26 Jun 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "2QK Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Scholar Rock Holding Corp. (2QK) stock, including analyst price targets, ratings, and financial performance. It covers historical stock prices, upcoming earnings dates, recent financial results, and details about the company's revenue, net inc", "url": "https://www.tradingview.com/symbols/SWB-2QK/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T00:41:26", "published_display": "26 Jun 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding Corp stock hits 52-week high at 52.21 USD", "summary": "Scholar Rock Holding Corp (SRRK) has reached a new 52-week high of $52.19, with shares trading around $52.11, marking a 53.5% surge over the past year. This achievement is backed by analyst optimism, with four analysts revising earnings estimates upward, despite its InvestingPro ", "url": "https://www.investing.com/news/company-news/scholar-rock-holding-corp-stock-hits-52week-high-at-5221-usd-93CH-4758398", "source_name": "Investing.com", "published_at": "2026-06-24T15:11:00", "published_display": "24 Jun 2026 15:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding eyes key EMA decision, shares trade higher on NASDAQ", "summary": "Scholar Rock Holding is nearing a key EMA review decision for its lead SMA therapy, apitegromab, which is scheduled for June 30, 2026. This comes ahead of a US FDA PDUFA date on September 30, 2026, after a recent resubmission of its biologics license application. The company's sh", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/scholar-rock-holding-eyes-key-ema-decision-shares-trade-higher-on-nasdaq/69611814", "source_name": "AD HOC NEWS", "published_at": "2026-06-23T15:09:23", "published_display": "23 Jun 2026 15:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding (SRRK) Is Up 7.1% After Apitegromab BLA Resubmission And Dual Supply Strategy - Has The Bull Case Changed?", "summary": "Scholar Rock Holding (SRRK) recently resubmitted its biologics license application for apitegromab, which now includes two fill-finish facilities and has a PDUFA date of September 30, 2026. This dual supply strategy aims to reduce operational risk for the spinal muscular atrophy ", "url": "https://www.sahmcapital.com/news/content/scholar-rock-holding-srrk-is-up-71-after-apitegromab-bla-resubmission-and-dual-supply-strategy-has-the-bull-case-changed-2026-06-23", "source_name": "Sahm", "published_at": "2026-06-22T15:40:10", "published_display": "22 Jun 2026 15:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/scholar-rock-showcase-neuromuscular-research-120000135.html", "source_name": "Business Wire", "published_at": "2026-06-22T12:00:00+00:00", "published_display": "22 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock brings new apitegromab data to two rare muscle-disease meetings", "summary": "Scholar Rock (NASDAQ: SRRK) announced it will present new clinical data and research updates related to its neuromuscular portfolio, including the Phase 3 SAPPHIRE and Phase 2 FORGE studies, at two upcoming meetings. The data will be shared at the 2026 Annual Cure SMA Research an", "url": "https://www.stocktitan.net/news/SRRK/scholar-rock-to-showcase-neuromuscular-research-portfolio-at-2026-8iyu5j9lsh59.html", "source_name": "Stock Titan", "published_at": "2026-06-22T12:12:38", "published_display": "22 Jun 2026 12:12", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding (SRRK) Stock Could Be 14.1% Undervalued On Its SMA Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding Corp (SRRK) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Scholar Rock Holding Corp (SRRK), detailing its current earnings forecast score, analyst ratings, and price targets. It highlights that the company's stock has an average price target of $47.50, with a majority of analysts recommendi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-srrk/earnings", "source_name": "TradingKey", "published_at": "2026-06-19T13:39:36", "published_display": "19 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cantor Fitzgerald reiterates Overweight on Scholar Rock stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQQTRUbFFobzNvUUZQX1RkVTdyalhOSDNPNlMzQmpXUEE3Wmo3dDRPWEtKdFFkNjRhY2hsMGFWQl84MDF1c0tMWnJadEY5WE1PQklMSFJ4MEN3aUpwMjNJQU5UX2ZxTkoyVG1ld3NITkU2S3gzV29yYV9NNlN5VjRiNTI2WGNKT0c5WlhVU2FZSno3dHowQ1JhQTlOZ016bktKam1mWFFTdlFhNDZEVzlNZ2tpbEV5WXBHV1NrUU9n?oc=5", "source_name": "Investing.com", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (NASDAQ: SRRK) director receives new RSU and stock option grants", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQR0ZMTWZyemR5cmpXWUNIbURHeFNzUFhnVHFzSGJMa01yR0NjbnZJQzFFQnl5VUdmRS1ubW52MVpoVm5QTWhNSUN4YUw5S1Z5Znlsd212R1I3aDVFdFQybFNPRklQZ2pDb1NGcUoyeEZyV2FZSEZNMWc5M1hGaUNrNFFCVEdMSm1tR0d6UWpnQUM0alNvbFNaQUttckVTM0RsNDRIeGFOZXdLNjIwTWxCTk10b1kxVFE4bXFn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Holding stock (US8063231019): fresh Nasdaq inducement grants highlight SMA hiring push", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNT3ZBSXNhLXRIaDVtdjV1SFVTejhnY05GaUFzSXFQYmdkbHJ1el9TWmRzV09GVDlTMEpMV19SUWRwUmFwbWtyUEtFbTVwOTBOV0k0T2doLVNGaTZ2c09pQ25VRnBqOVVTOUpEb1NIQjhmcE10MTMzVGY4R0xEdnpxbTcyRmVJTkFna211Y2ExczQ4TEZ1a0hTZVY0N0NBaGRJcDZVQjZnc3FUcV9QMlY4ekJaR1pkaEZTbEVPNnVPSmo0T3pUdy13Nw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Scholar Rock Q1 2026 sees EPS miss, stock rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQTWY4VzV3MHJqRzhWLTVyaVRLVDBIUlhvbHkxUk4tQmlvYVAzbndqRXprTGVuOF92TWFoZ3RtSGRJQ05Ub1hrOHJPb19qMUVXZzFwcHB1M3ZMUUJHcXp2VDh0c0J5dUI2RGhBcHV5Z3cxa2hDY0MyVHZtNEU1ak9pY25UQXRza2dKbHFkWmQ0Q05oMTBXal90NkRseEJRQXl2OUxpM3VWcGJNYXBlaHhqWXVoYmVmTW1PdXFQZlE4QXd0VDJLRUE?oc=5", "source_name": "Investing.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Scholar Rock Holding (SRRK) Offering Value After Its Strong Multi Year Share Price Gains", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/4248ce74-fce5-38f3-bfc8-fb0d3ad1ba39/scholar-rock-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-09T02:05:47+00:00", "published_display": "09 May 2026 02:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock (SRRK) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/e139581e-917f-3156-94db-0423cb0ec2be/scholar-rock-%28srrk%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-08T15:30:48+00:00", "published_display": "08 May 2026 15:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Scholar Rock (SRRK) Valuation After Strong Multi Year Shareholder Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPR3BNNmtGMTZLb3JhLXpMb2hSYkF1RURNeDhXZWVYSVF5ekkyR1NjcXhpR3lodDhMQnhqZnJUNlh2NFZGd3FjQTFpb0lmTGFmdTRiTGZuZlJJRTh5R2NseXZnRDl6ZTZlSW5MeTA4a0VfV0FFQTVSbWV1OGg1bDFWUUlwN0NsUzFnVEpJZDVPSGdqclRxQmtPWWZZOVlRdw?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Don't Ignore The Insider Selling In Scholar Rock Holding", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scholar Rock's SMA drug heads back to FDA; decision due by late Sept.", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPdDRPbmctWXk1MXBLME51cGxndzUxVTBwRXJDdUFGQ1ZGRFk5cHlSSGlyLXhhOTJHZ25jYnh2RjZVNEt0Yk41OEF4cG56T2lvV0dnZ3F0VUtNeXpTRzE0cThtRjM5c21YSlZFcTBWNHlrTkg2MlpDenN3ZzlwTThlUVowWHYtcmJGZmwtaUt3Q0dnWEJpSmd4bXVTY3JvU2NTSnJGYzh5bHdtNzhGdEhUUlB0eW1XU0VFZXFpTTVtbw?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Scholar Rock Holding (SRRK) Valuation As Growth Expectations Face Mixed Share Price Signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNYWtUbGk5MDM2ZThJQWtEREt0N25lek5PaVpWSVhnMF9jRHB3aGEtVkZDZXAyNEd3SFFtQ0Y2MU1iclZkNXlTUEZ1bUlMeFBhcnZxOHBoS3VDel9rR0syVmtONy1PeVY4M3hvU2xZdkQ4emZIRF9lQTZRcjJvQjhFMkRTRk1JMzd5QlVCb2xyWkE5b0ZLVXpuSy1RQQ?oc=5", "source_name": "Market source", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn\u2019t Pleased", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPeTlKeFlQNTdaT1MwVjYwc0FxNkhNdmpuRGFzWlN3OTJncEgzS1dsdG02V2hpQmxrcXBSZmFVU2UxeC1tX3o3U0k4VmhIQlNmTkFET1JyWHdRRkZnNzBoQmc5NWVSOXRzVGtfY2hKcUhlQURvSm4yRmllRHB4dkpJRml5MTVoLWNWLUZxQXJqeWZxYnFmdWVHajFhOEVmYUpDeXR2Wk0xWUszaHc2bmUteS1ReTJUZnBOLVh4WUxQMWlaNmZWNXRnMm40Qy1aOE43aG1VVUw0Z3llb3VYOG4tNFU1UQ?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US FDA declines to approve Scholar Rock's muscle weakness drug; shares fall", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPd2RTZW5WNmxXcGZ5a05kM1p1bXFzNXJLMV8tb1ROVVF2S0NPUzcyY1h6OFlYd0xGaENFdklsZEk2OUpFdC0wajN2ZWVRNUhwT0l6anc0SnpaeHdIakp3bmZxWGhkT194TEZCal9zVU5qRHJXOE9YWUZwN3ctd1FEOElmX2xKdURrN0R1UXEyclA0ZWNOSWpEOU9nbDZfTW5oZXU2bXlic0Q1b1QyT3hGWmd1N2FFSGozREFwUXQySHFQR2NoT081Yk5R?oc=5", "source_name": "Reuters", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "negative", "sentiment_pct": 6, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 98, "total_relevant": 57, "sentiment_summary": {"positive": 14, "negative": 6, "neutral": 37, "score": 53, "total": 57, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 17.4, "count": 31}, {"event": "earnings", "label": "Earnings", "weight": 10.45, "count": 21}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}], "positive_events": 14, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 52.86, "latest_week": "2026-07-17", "one_week_move": -6.8, "four_week_move": 11.7, "twelve_week_move": 13.7, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.887154, "market_dynamics_buy_signal": false, "relative_strength": 12.602993, "fair_value_gap": 89.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 52.2607, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-6.8% over one week, +11.7% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 12}, {"label": "Market source", "count": 8}, {"label": "simplywall.st", "count": 6}, {"label": "TradingView", "count": 6}, {"label": "Investing.com", "count": 4}, {"label": "Business Wire", "count": 3}, {"label": "Quartr", "count": 3}, {"label": "MarketBeat", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 49}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 31}, {"label": "Earnings", "count": 21}, {"label": "Analyst action", "count": 3}, {"label": "Regulatory and legal", "count": 1}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "49", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-6.8% over one week, +11.7% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)"}], "updated_at": "2026-07-18T21:27:38.672496+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}